Free Daily Podcast Summary
Pharmaceutical Executive: Daily Summaries Delivered
by Pharmaceutical Executive Podcast
The Pharm Exec Podcast goes beyond the pages of the Pharmaceutical Executive print magazine and PharmExec.com to bring the latest commercial insights to the C-suite through in-depth interviews. Podcast episodes examine current trends, key conferences, and critical topics in the industry.
Latest Episodes
The most recent episodes — sign up to get AI-powered summaries of each one.
- 3 days ago2 min
Pharmaceutical Executive Daily: FDA Approves Voceryq
FDA grants accelerated approval to INOVIO’s Voceryq to reduce surgical burden in recurrent respiratory papillomatosis, Brox.AI’s Hamish Brocklebank on the three levels of digital clone use cases in pharma, and CytoDyn’s Dr. Jay Lalezari on his path from HIV clinician to CEO.
- 3 days ago32 min
States Take Center Stage in the Drug Pricing Fight
In this episode of the Pharmaceutical Executive podcast, Scott LaGanga, executive vice president of state advocacy at PhRMA, discusses the expanding influence of state policymaking on drug pricing, pharmacy benefit manager reform, and efforts to translate policy changes into lower out-of-pocket costs for patients. Joining Mike Christel, group managing editor, MJH Life Sciences, LaGanga also dives into the potential impact of tomorrow's U.S. midterm elections in shaping the next wave of drug pricing policy in state capitals as much as in Washington.Noting the high stakes, LaGanga explains why turnover in governors’ offices and state legislatures puts fresh urgency on educating policymakers about the pharmaceutical supply chain — and how decisions in states can move quickly and spread across the country. He also considers how the presidential campaign cycle that follows could bring local health care access and affordability concerns further into the national debate.
- 1 weeks ago2 min
Pharmaceutical Executive Daily: Pathos AI Enters Collaboration with Bristol Myers Squibb
Bristol Myers Squibb discloses a patient death in its Phase I CAR-T multiple sclerosis trial, Pathos AI launches multi-year collaborations with Bristol Myers Squibb and Tempus AI to advance Alzheimer’s drug development, and health economist Dr. Nadine Zawadzki speaks with The Ron Lanton Report on how value is defined across healthcare.
- 1 weeks ago37 min
The Ron Lanton Report: A Conversation with Dr. Nadine Zawadzki
Pharmaceutical and health economist Dr. Nadine Zawadzki, Senior Director, FTI Consulting joins the Ron Lanton Report to discuss how value is defined and measured across healthcare.
- 1 weeks ago2 min
Pharmaceutical Executive Daily: Treasury Issues Notice to Add Biotech into Proposed COINS Act
Treasury proposes adding biotechnology to its Outbound Investment Security Program, a pharma funding roundup covers Gilead’s $1.275 billion acquisition of an oral IL-23R inhibitor from PepStar and Zymeworks’ licensing deal with Roche, and Incubate’s John Stanford on why MFN is an offer pharma can’t refuse.
- 1 weeks ago37 min
Building Biopharma Manufacturing for Speed, Scale, and Flexibility
Biopharma manufacturing today is being asked to move faster, accommodate increasingly complex modalities, and respond more readily to changing development timelines and demand forecasts — all while maintaining reliable, compliant, and cost-effective supply. In this episode of the Pharm Exec Podcast, Dave Maraldo, Ph.D., executive vice president and president of the Merck Manufacturing Division, draws on 27 years at the company to explore that evolution. He discusses Merck’s major U.S. capacity investments; its approach to balancing internal capabilities with strategic manufacturing partners; and the closer integration of research, development, and production.Joining Mike Christel, group managing editor, MJH Life Sciences, Maraldo also examines the practical impact of digital tools and artificial intelligence and how Merck is building greater agility and resilience into its global supply network. He reflects ahead as well on what the next generation of manufacturing talent will require and why he thinks patient needs will move closer and closer to the shop floor.
- 2 weeks ago2 min
Pharmaceutical Executive Daily: FDA Grants Ultomiris Accelerated Approval in the U.S.
FDA grants Ultomiris accelerated approval for primary immunoglobulin A nephropathy, a pharma funding roundup covers Alcon’s $550 million acquisition of Neurotech and AI Proteins’ collaboration with Astellas, and Incubate’s John Stanford on which therapeutic areas MFN deals might hit hardest.
- 2 weeks ago2 min
Pharmaceutical Executive Daily: FDA Approves Hibsago
A new ICER and West Health report finds median drug launch prices climbed to $257,000, the FDA approves GSK’s Hibsago as the first functional-cure therapy for chronic hepatitis B, and CSL names Deborah Waterhouse as CEO and managing director.
Get Pharmaceutical Executive summaries in your inbox
Free AI-powered daily recaps. Key takeaways, quotes, and mentions — in a 5-minute read.
Get Free Summaries →Free forever for up to 3 podcasts. No credit card required.
You Might Also Like
Listeners also like.
The BioHub - by Avetix
Conversations with leading biotech experts reveal the strategies and stories driving innovation in the biotechnology industry.
FDA Watch
A regulatory expert hosts discussions on FDA policies and developments across pharmaceuticals, devices, food, and cosmetics.
In the Interim...
Explores Bayesian statistics and adaptive clinical trial designs in medical research with insights from industry experts.
The VPZD Show
Two physicians discuss healthcare, medicine, and policy from a contrarian, middle-ground perspective.
DGTL Voices with Ed Marx
Conversations with leaders and innovators driving digital transformation in healthcare.
PSYCHOACTIVE
Explores humanity's complex relationship with drugs through conversations with users, experts, and critics.
The AI XR Podcast.
Insightful interviews with tech founders and executives on AI, virtual reality, augmented reality, and the future of spatial computing.
The AI in Business Podcast
Interviews with AI executives reveal practical applications and strategic insights for business leaders adopting AI.
Solutions with Henry Blodget
Henry Blodget interviews experts in business, tech, and politics about practical solutions for building a better future.
The Hunter Williams Podcast
Explores cutting-edge science in peptides, hormone optimization, and biohacking with experts pushing the limits of human performance.
HBR IdeaCast
Features leading thinkers in business and management discussing key ideas and trends.
Leading By Example: Executives Making An Impact
Executives share pivotal moments and personal experiences that shaped their leadership and decision-making in real-world business environments.
About Pharmaceutical Executive
The Pharm Exec Podcast goes beyond the pages of the Pharmaceutical Executive print magazine and PharmExec.com to bring the latest commercial insights to the C-suite through in-depth interviews. Podcast episodes examine current trends, key conferences, and critical topics in the industry.
Customized Recaps
AI-powered recaps with compact key takeaways, quotes, and insights.
Straight to Your Inbox
Get key takeaways from Pharmaceutical Executive in a 5-minute read.
Save Hours Every Week
Stay current on your favorite podcasts without falling behind.
Frequently Asked Questions
What is Podzilla's Pharmaceutical Executive daily summary?
It's a free AI-powered email that summarizes new episodes of Pharmaceutical Executive as soon as they're published. You get the key takeaways, notable quotes, and links & mentions — all in a quick read.
How does the Pharmaceutical Executive podcast summary work?
When a new episode drops, our AI transcribes and analyzes it, then generates a personalized summary tailored to your interests and profession. It's delivered to your inbox every morning.
Is this an official Pharmaceutical Executive product?
No. Podzilla is an independent service that summarizes publicly available podcast content. We're not affiliated with or endorsed by Pharmaceutical Executive Podcast.
Can I get summaries of other podcasts too?
Absolutely! The free plan covers up to 3 podcasts, any in the catalog. Basic raises that to 15, Pro to 40 and Max to 100. Browse our full catalog at /podcasts.
How often does Pharmaceutical Executive release new episodes?
Pharmaceutical Executive publishes daily. Our AI generates a summary within hours of each new episode.
What topics does Pharmaceutical Executive cover?
Pharmaceutical Executive covers topics including Science, Life Sciences. Our AI identifies the specific themes in each episode and highlights what matters most to you.
Start getting Pharmaceutical Executive summaries tomorrow morning.
Free forever for up to 3 podcasts. No credit card required.
Free forever for up to 3 podcasts. No credit card required.